Department of Clinical Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou 215008, China.
Zhejiang University School of Medicine, Hangzhou 310030, China.
Hepatobiliary Pancreat Dis Int. 2023 Aug;22(4):346-351. doi: 10.1016/j.hbpd.2023.03.010. Epub 2023 Mar 25.
Hepatocellular carcinoma (HCC) is a common malignant tumor. At present, early diagnosis of HCC is difficult and therapeutic methods are limited. Radiomics can achieve accurate quantitative evaluation of the lesions without invasion, and has important value in the diagnosis and treatment of HCC. Radiomics features can predict the development of cancer in patients, serve as the basis for risk stratification of HCC patients, and help clinicians distinguish similar diseases, thus improving the diagnostic accuracy. Furthermore, the prediction of the treatment outcomes helps determine the treatment plan. Radiomics is also helpful in predicting the HCC recurrence, disease-free survival and overall survival. This review summarized the role of radiomics in the diagnosis, treatment and prognosis of HCC.
肝细胞癌（HCC）是一种常见的恶性肿瘤。目前，HCC 的早期诊断较为困难，治疗方法也有限。放射组学可以实现对病变的非侵入性精确定量评估，在 HCC 的诊断和治疗中具有重要价值。放射组学特征可预测患者癌症的发展，为 HCC 患者的风险分层提供依据，并有助于临床医生区分相似疾病，从而提高诊断准确性。此外，对治疗效果的预测有助于确定治疗方案。放射组学在预测 HCC 的复发、无病生存和总生存方面也有帮助。本文综述了放射组学在 HCC 的诊断、治疗和预后中的作用。
